Project 2: Molecular Signatures of West Nile virus susceptibility
项目 2:西尼罗河病毒易感性的分子特征
基本信息
- 批准号:10317021
- 负责人:
- 金额:$ 114.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-15 至 2021-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAntibody RepertoireBlood PlateletsBlood specimenCOVID-19CellsCellular AssayCessation of lifeClinicalCytometryDataData AnalysesDevelopmentDiagnosticDiseaseDisease OutcomeEnrollmentExposure toFlavivirusFrequenciesFutureGene TargetingGenesHealthHepatitis C virusHumanImage CytometryImmuneImmune responseImmunityImmunologic MarkersImmunophenotypingIndividualInfectionInvestigationLibrariesLinkMass Spectrum AnalysisMeasurementMetabolicMetabolic PathwayModelingMolecular ProfilingOutcomePathogenicityPathway interactionsPhenotypePopulationPredispositionResearchResolutionSamplingSerumSeveritiesSeverity of illnessShapesSystemSystems AnalysisT-LymphocyteTechnologyTherapeutic InterventionTimeVaccinesValidationVariantVirusWest Nile viral infectionWest Nile virusWhole Bloodadaptive immunitybasecell typecohortdata integrationdata managementeffective therapyexperiencefunctional statushelicasehuman subjectimmune functionimmunological statusimprovedindividual variationinnovationinsightmetabolic profilemetabolomicsmodel developmentneutrophilnovelresponsesharing platformsingle-cell RNA sequencingtranscriptome sequencingvaccine access
项目摘要
Abstract
Individual variations in immune status and function shape responses to infection and contribute to
disease severity and outcome. Infections with West Nile virus can be asymptomatic or severe, even
leading to death, and no effective therapies or vaccines are available. Thus, identifying molecular
signatures of immunity and phenotypes of susceptibility is essential to guide development of improved
diagnostics, therapeutic interventions and future vaccines. We propose studies with a coordinated
Systems approach for investigation of stratified subjects with West Nile viral infections to define how
components of the immune response contribute to divergent outcomes. We will employ recent advances
in high-throughput and high-resolution technology to profile individual immune responses in order to
identify the molecular signatures defining divergent responses to West Nile virus infections. We
will use shared platforms such as CyTOF, metabolomics, and innovative nanowell cytometry linked to
single cell RNA-seq to provide insight into the immune responses to WNV. Our coordinated in-depth
systems analysis includes for the first time the phenotype and functionality of neutrophils, platelets, and
metabolomics in divergent clinical outcomes. Through integrating multiple immune components, we will
define response profiles that correlate with successful outcome of infection. Strengths of our proposal are
the well characterized clinical populations, the coordinated in-depth interrogation of multiple cell types
and responses, the experienced and coordinated research team, the interrogation and integration of
multiple variables that influence immune responses, and established HIPC consortium networks.
摘要
免疫状态和功能的个体差异塑造了对感染的反应,
疾病的严重程度和结果。感染西尼罗河病毒可以是无症状的或严重的,
导致死亡,并且没有有效的治疗或疫苗可用。因此,识别分子
免疫特征和易感性表型对于指导改进的
诊断、治疗干预和未来的疫苗。我们建议进行协调的研究
研究西尼罗河病毒感染分层受试者的系统方法,以确定如何
免疫反应的不同组成部分导致不同的结果。我们将利用最新的进展
在高通量和高分辨率技术中,以描绘个体免疫应答,
确定对西尼罗河病毒感染的不同反应的分子特征。我们
将使用共享平台,如CyTOF,代谢组学和创新的细胞计数,
单细胞RNA-seq,以提供对WNV免疫反应的洞察。我们协调的深入
系统分析首次包括中性粒细胞、血小板和
代谢组学在不同的临床结果。通过整合多种免疫成分,
定义与感染成功结果相关的反应概况。我们的建议的优点是
良好表征的临床人群,多种细胞类型的协调深入询问
和反应,经验丰富和协调的研究团队,审讯和整合,
影响免疫反应的多种变量,并建立了重债穷国联盟网络。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUTH R MONTGOMERY其他文献
RUTH R MONTGOMERY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUTH R MONTGOMERY', 18)}}的其他基金
Inflammatory dysregulation of vaccine responses in sickle cell disease
镰状细胞病疫苗反应的炎症失调
- 批准号:
10420328 - 财政年份:2010
- 资助金额:
$ 114.92万 - 项目类别:
Inflammatory dysregulation of vaccine responses in sickle cell disease
镰状细胞病疫苗反应的炎症失调
- 批准号:
10617772 - 财政年份:2010
- 资助金额:
$ 114.92万 - 项目类别:
相似海外基金
The evolution of dengue virus-reactive circulating antibody repertoire
登革热病毒反应性循环抗体库的进化
- 批准号:
10647572 - 财政年份:2023
- 资助金额:
$ 114.92万 - 项目类别:
The Anti-Cyclic Citrullinated Protein Antibody Repertoire and Lung Involvement in Rheumatoid Arthritis
类风湿性关节炎中的抗环瓜氨酸蛋白抗体库和肺参与
- 批准号:
10252749 - 财政年份:2020
- 资助金额:
$ 114.92万 - 项目类别:
Antibody repertoire characterization in the context of coronaviruses
冠状病毒背景下的抗体库表征
- 批准号:
10266227 - 财政年份:2020
- 资助金额:
$ 114.92万 - 项目类别:
Molecular analysis of antibody repertoire elicited after yellow fever vaccination
黄热病疫苗接种后产生的抗体库的分子分析
- 批准号:
10401404 - 财政年份:2019
- 资助金额:
$ 114.92万 - 项目类别:
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection
人类侵袭性感染后针对金黄色葡萄球菌杀白细胞素的功能性抗体库
- 批准号:
10092085 - 财政年份:2019
- 资助金额:
$ 114.92万 - 项目类别:
Molecular analysis of antibody repertoire elicited after yellow fever vaccination
黄热病疫苗接种后产生的抗体库的分子分析
- 批准号:
10578848 - 财政年份:2019
- 资助金额:
$ 114.92万 - 项目类别:
Molecular analysis of antibody repertoire elicited after yellow fever vaccination
黄热病疫苗接种后产生的抗体库的分子分析
- 批准号:
9882945 - 财政年份:2019
- 资助金额:
$ 114.92万 - 项目类别:
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection
人类侵袭性感染后针对金黄色葡萄球菌杀白细胞素的功能性抗体库
- 批准号:
10541163 - 财政年份:2019
- 资助金额:
$ 114.92万 - 项目类别:
Understanding Early-life Influenza Antibody Repertoire Imprinting Through Infection or Vaccination
了解生命早期流感抗体库通过感染或疫苗印记
- 批准号:
10215742 - 财政年份:2019
- 资助金额:
$ 114.92万 - 项目类别:
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection
人类侵袭性感染后针对金黄色葡萄球菌杀白细胞素的功能性抗体库
- 批准号:
10326846 - 财政年份:2019
- 资助金额:
$ 114.92万 - 项目类别:














{{item.name}}会员




